Plus, news about Generation Bio, Response Pharmaceuticals, Jocasta Neuroscience, Oric, ALX Oncology, Fate Therapeutics, X4 Pharmaceuticals and Armata:
🧭 Compass Therapeutics sells $120M in shares: The Boston-based biotech plans to
↧